Clinical Trial


This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure


Brief description

The study will evaluate the efficacy and safety of LCZ696 compared to enalapril on morbidity and mortality in patients with chronic heart failure (NYHA Class II - IV and EF =< 35%).

Keywords

  •   Heart Failure With Reduced Ejection Fraction

Sponsored By

Novartis Pharmaceuticals

Unique Study ID

NCT01035255

Investigators and Research Sites Near You - Found( 3 )

Fabrice Gankam, Dr.

Universiteit Antwerpen
Baudour, Belgium
Distance from Current Trial is 0 miles

No Investigator Listed

Astellas Pharma Inc
7331, Baudour, Belgium
Distance from Current Trial is 0 miles

No Investigator Listed

Universitaire Ziekenhuizen Leuven
7331, Baudour, Belgium
Distance from Current Trial is 0 miles
View All